Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,705 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomarkers for amyotrophic lateral sclerosis.
Witzel S, Mayer K, Oeckl P. Witzel S, et al. Among authors: mayer k. Curr Opin Neurol. 2022 Oct 1;35(5):699-704. doi: 10.1097/WCO.0000000000001094. Epub 2022 Aug 4. Curr Opin Neurol. 2022. PMID: 35942674 Review.
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S; VALOR and OLE Working Group. Miller TM, et al. N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705. N Engl J Med. 2022. PMID: 36129998 Free article. Clinical Trial.
Clinical and genetic features of amyotrophic lateral sclerosis patients with C9orf72 mutations.
Wiesenfarth M, Günther K, Müller K, Witzel S, Weiland U, Mayer K, Herrmann C, Brenner D, Schuster J, Freischmidt A, Lulé D, Meyer T, Regensburger M, Grehl T, Emmer A, Petri S, Großkreutz J, Rödiger A, Steinbach R, Klopstock T, Reilich P, Schöberl F, Wolf J, Hagenacker T, Weyen U, Zeller D, Ludolph AC, Dorst J. Wiesenfarth M, et al. Among authors: mayer k. Brain Commun. 2023 Mar 21;5(2):fcad087. doi: 10.1093/braincomms/fcad087. eCollection 2023. Brain Commun. 2023. PMID: 37006326 Free PMC article.
Effects of tofersen treatment in patients with SOD1-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access program.
Wiesenfarth M, Dorst J, Brenner D, Elmas Z, Parlak Ö, Uzelac Z, Kandler K, Mayer K, Weiland U, Herrmann C, Schuster J, Freischmidt A, Müller K, Siebert R, Bachhuber F, Simak T, Günther K, Fröhlich E, Knehr A, Regensburger M, German A, Petri S, Grosskreutz J, Klopstock T, Reilich P, Schöberl F, Hagenacker T, Weyen U, Günther R, Vidovic M, Jentsch M, Haarmeier T, Weydt P, Valkadinov I, Hesebeck-Brinckmann J, Conrad J, Weishaupt JH, Schumann P, Körtvélyessy P, Meyer T, Ruf WP, Witzel S, Senel M, Tumani H, Ludolph AC. Wiesenfarth M, et al. Among authors: mayer k. EClinicalMedicine. 2024 Feb 15;69:102495. doi: 10.1016/j.eclinm.2024.102495. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38384337 Free PMC article.
Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome.
Bien CG, Bien CI, Dogan Onugoren M, De Simoni D, Eigler V, Haensch CA, Holtkamp M, Ismail FS, Kurthen M, Melzer N, Mayer K, von Podewils F, Rauschka H, Rossetti AO, Schäbitz WR, Simova O, Witt K, Höftberger R, May TW. Bien CG, et al. Among authors: mayer k. J Neurol. 2020 Jul;267(7):2101-2114. doi: 10.1007/s00415-020-09814-3. Epub 2020 Apr 3. J Neurol. 2020. PMID: 32246252 Free PMC article.
Correction to: Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome.
Bien CG, Bien CI, Onugoren MD, De Simoni D, Eigler V, Haensch CA, Holtkamp M, Ismail FS, Kurthen M, Melzer N, Mayer K, von Podewils F, Rauschka H, Rossetti AO, Schäbitz WR, Simova O, Witt K, Höftberger R, May TW. Bien CG, et al. Among authors: mayer k. J Neurol. 2021 Aug;268(8):3056-3057. doi: 10.1007/s00415-021-10634-2. J Neurol. 2021. PMID: 34170405 Free PMC article. No abstract available.
Correction to: Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome.
Bien CG, Bien CI, Dogan Onugoren M, De Simoni D, Eigler V, Haensch CA, Holtkamp M, Ismail FS, Kurthen M, Melzer N, Mayer K, von Podewils F, Rauschka H, Rossetti AO, Schäbitz WR, Simova O, Witt K, Höftberger R, May TW. Bien CG, et al. Among authors: mayer k. J Neurol. 2020 Jul;267(7):2115-2116. doi: 10.1007/s00415-020-09855-8. J Neurol. 2020. PMID: 32399693 Free PMC article.
Barriers to engagement in the care cascade for tuberculosis disease in India: A systematic review of quantitative studies.
Jhaveri TA, Jhaveri D, Galivanche A, Lubeck-Schricker M, Voehler D, Chung M, Thekkur P, Chadha V, Nathavitharana R, Kumar AMV, Shewade HD, Powers K, Mayer KH, Haberer JE, Bain P, Pai M, Satyanarayana S, Subbaraman R. Jhaveri TA, et al. Among authors: mayer kh. PLoS Med. 2024 May 28;21(5):e1004409. doi: 10.1371/journal.pmed.1004409. Online ahead of print. PLoS Med. 2024. PMID: 38805509 Free article.
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
Mayer KA, Schrezenmeier E, Diebold M, Halloran PF, Schatzl M, Schranz S, Haindl S, Kasbohm S, Kainz A, Eskandary F, Doberer K, Patel UD, Dudani JS, Regele H, Kozakowski N, Kläger J, Boxhammer R, Amann K, Puchhammer-Stöckl E, Vietzen H, Beck J, Schütz E, Akifova A, Firbas C, Gilbert HN, Osmanodja B, Halleck F, Jilma B, Budde K, Böhmig GA. Mayer KA, et al. N Engl J Med. 2024 May 25. doi: 10.1056/NEJMoa2400763. Online ahead of print. N Engl J Med. 2024. PMID: 38804514
High Rates of Missed HIV Testing Among Oral PrEP Users in the United States From 2018-2021: A National Assessment on Compliance With HIV Testing Recommendations of the CDC PrEP Guidelines.
Baron J, Tchelidze T, LaBrot B, Yao J, Mayer KH, Kuritzkes D, Robinson N, Patel RR. Baron J, et al. Among authors: mayer kh. Open Forum Infect Dis. 2024 May 23;11(5):ofae254. doi: 10.1093/ofid/ofae254. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38798900 Free PMC article.
2,705 results